Grants & Programs


At this time of change and progress in the field of cancer immunology, members of the Cancer Immunotherapy Consortium (CIC) create a single and powerful voice within the biomedical research community to address the networking, clinical, and regulatory needs of academic scientists, corporations, and organizations working in this promising area of biomedicine. CIC members provide data-driven solutions to scientific and developmental challenges and help to validate and accelerate the development and approval of effective cancer immunotherapies.

A growing list of more than 110 organizations belong to the Cancer Immunotherapy Consortium, including many of the world's leading biotech and biopharmaceutical companies and academic research universities and medical centers.

Academic Members

  • Armauer Hansen Research Institute
    Centre for International Health Research (CRESIB) Barcelona
    Baylor Institute for Immunology Research
    Benaroya Research Institute
    Cancer Trials Australia
    Cardiff University School of Medicine
    Center of Molecular Immunology
    City of Hope
  • Dana-Farber Cancer Institute
    Dartmouth Medical School
    DeAR Lab Avenir, INSERM U986
    Deeley Research Centre/British Columbia Cancer Agency
    Duke University Medical Center
    Earle A. Chiles Research Institute
    Fondazione IRCCS Istituto Nazionale dei Tumori
    Fred Hutchinson Cancer Research Center
  • The George Washington Cancer Institute
    Georgia Regents University Cancer Center
    Helmholtz Zentrum Muenchen
    Hoag Hospital
    Imperial College London
    Institut Curie
    Johannes Gutenberg-Universität Mainz
    Johns Hopkins University School of Medicine
  • Kawasaki University of Medical Welfare
    Krankenhaus Nordwest
    Le Centre de Lutte Contre le Cancer Nantes Atlantique René Gauducheau
    Leiden University Medical Center
    London School of Hygiene and Tropical Medicine
    Loyola University Medical Center, Chicago
    Ludwig-Maximilans Universität München
    Martin Luther University Halle-Wittenberg
  • Massachusetts General Hospital
    Max-Planck Institute für Infektionsbiologie
    McMaster University
    Medical University of Lublin
    Memorial Sloan-Kettering Cancer Center
    Mercy Cancer Center
    Mie University
    Moffitt Cancer Center
  • National Cancer Center Hospital (Japan)
    National Cancer Institute "Pascale"
    National Institutes of Health
    National Jewish Health
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
    New York University School of Medicine
    Northern California Melanoma Center
    Okayama University Medical School
  • Osaka University
    Paterson Institute for Cancer Research, University of Manchester
    Regina Elena National Cancer Institute
    Reliable Cancer Therapies
    The Rockefeller University
    Roswell Park Cancer Institute
    Stanford University
    Swedish Institute for Infectious Disease Control
  • Tbilisi State Medical University
    Université de Montréal
    University Hospital Lausanne
    University Hospital Zürich
    University Medical Center Hamburg-Eppendorf
    University of Antwerp
    University of Crete
    University of Erlangen-Nürnberg
  • University of Genoa, Italy
    University of Heidelberg
    University of Minnesota Masonic Cancer Center
    University of Oxford
    University of Pennsylvania School of Medicine
    University of Pittsburg Cancer Institute
    University of Southampton
    University of Texas MD Anderson Cancer Center
  • University of Texas Southwestern Medical Center
    University of the Witwatersrand
    University of Tübingen
    University of Virginia Health System
    University of Washington, Seattle
    University of Wisconsin Carbone Cancer Center
    Vanderbilt University Medical Center
    VU University Medical Center Amsterdam
  • Walter Reed Army Institute of Research
    Washington University School of Medicine
    Weill Medical College of Cornell University